found that GLP-1RAs did not significantly reduce asthma exacerbations, whereas, SGLT-2 inhibitors (SGLT-2i) were associated with a reduced risk of asthma compared to both GLP-1RAs and DPP-4 inhibitors (DPP-4i) [101]
It is water-soluble for red blood cell formation, DNA synthesis, and healthy nerves
However, the risk of counterfeit products and lack of regulation make purchasing BPC 157 for personal use risky and potentially illegal
Fernandez, D.U.M., Arbulu, S., Garcia-Gutierrez, E., and Cotter, P.D., Front
Another trial in 54 individuals confirmed its safety over 10 days of intravenous use at doses of up to 5.0g/kg (and up to 25.0g/kg in a single-dose trial)